CN114699493A - 治疗荨麻疹、湿疹、过敏/变态反应体质的中药组方 - Google Patents
治疗荨麻疹、湿疹、过敏/变态反应体质的中药组方 Download PDFInfo
- Publication number
- CN114699493A CN114699493A CN202210353546.XA CN202210353546A CN114699493A CN 114699493 A CN114699493 A CN 114699493A CN 202210353546 A CN202210353546 A CN 202210353546A CN 114699493 A CN114699493 A CN 114699493A
- Authority
- CN
- China
- Prior art keywords
- traditional chinese
- chinese medicine
- allergic
- medicine
- urticaria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 174
- 208000010668 atopic eczema Diseases 0.000 title claims abstract description 72
- 208000024780 Urticaria Diseases 0.000 title claims abstract description 59
- 201000004624 Dermatitis Diseases 0.000 title claims abstract description 48
- 230000000172 allergic effect Effects 0.000 title claims abstract description 38
- 208000003251 Pruritus Diseases 0.000 claims abstract description 100
- 208000024376 chronic urticaria Diseases 0.000 claims abstract description 33
- 206010052568 Urticaria chronic Diseases 0.000 claims abstract description 16
- 230000001154 acute effect Effects 0.000 claims abstract description 14
- 230000001684 chronic effect Effects 0.000 claims abstract description 12
- 206010068172 Anal pruritus Diseases 0.000 claims abstract description 7
- 206010052613 Allergic bronchitis Diseases 0.000 claims abstract description 4
- 208000005577 Gastroenteritis Diseases 0.000 claims abstract description 4
- 206010039085 Rhinitis allergic Diseases 0.000 claims abstract description 4
- 208000025865 Ulcer Diseases 0.000 claims abstract description 4
- 201000010105 allergic rhinitis Diseases 0.000 claims abstract description 4
- 208000006820 Arthralgia Diseases 0.000 claims abstract 2
- 208000000112 Myalgia Diseases 0.000 claims abstract 2
- 208000013465 muscle pain Diseases 0.000 claims abstract 2
- 239000003826 tablet Substances 0.000 claims description 46
- 229940079593 drug Drugs 0.000 claims description 25
- 239000008187 granular material Substances 0.000 claims description 23
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 21
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 21
- 241000411851 herbal medicine Species 0.000 claims description 20
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 17
- 235000011477 liquorice Nutrition 0.000 claims description 17
- 235000006679 Mentha X verticillata Nutrition 0.000 claims description 15
- 235000002899 Mentha suaveolens Nutrition 0.000 claims description 15
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims description 15
- 241000205585 Aquilegia canadensis Species 0.000 claims description 14
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 14
- 235000008397 ginger Nutrition 0.000 claims description 14
- 241000132012 Atractylodes Species 0.000 claims description 13
- 239000006187 pill Substances 0.000 claims description 13
- 241000245665 Taraxacum Species 0.000 claims description 12
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims description 12
- 239000002674 ointment Substances 0.000 claims description 12
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims description 11
- 240000004534 Scutellaria baicalensis Species 0.000 claims description 11
- 239000002775 capsule Substances 0.000 claims description 11
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 10
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims description 10
- 235000004347 Perilla Nutrition 0.000 claims description 10
- 244000124853 Perilla frutescens Species 0.000 claims description 10
- 241000304195 Salvia miltiorrhiza Species 0.000 claims description 10
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims description 10
- 241000951473 Schizonepeta Species 0.000 claims description 10
- 208000015181 infectious disease Diseases 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- 235000001405 Artemisia annua Nutrition 0.000 claims description 9
- 240000000011 Artemisia annua Species 0.000 claims description 9
- 241000596154 Belamcanda Species 0.000 claims description 9
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 9
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 9
- 240000006766 Cornus mas Species 0.000 claims description 9
- 235000015489 Emblica officinalis Nutrition 0.000 claims description 9
- 241000218378 Magnolia Species 0.000 claims description 9
- 240000003705 Senecio vulgaris Species 0.000 claims description 9
- 235000011517 Terminalia chebula Nutrition 0.000 claims description 9
- 238000005516 engineering process Methods 0.000 claims description 9
- 239000002398 materia medica Substances 0.000 claims description 9
- 241000131458 Elsholtzia Species 0.000 claims description 8
- 241001071795 Gentiana Species 0.000 claims description 8
- 241000112528 Ligusticum striatum Species 0.000 claims description 8
- 241000206469 Pulsatilla Species 0.000 claims description 8
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims description 8
- 210000000582 semen Anatomy 0.000 claims description 8
- 240000004510 Agastache rugosa Species 0.000 claims description 7
- 241000213006 Angelica dahurica Species 0.000 claims description 7
- 241000037740 Coptis chinensis Species 0.000 claims description 7
- 235000003889 Paeonia suffruticosa Nutrition 0.000 claims description 7
- 240000005001 Paeonia suffruticosa Species 0.000 claims description 7
- 241000218989 Trichosanthes Species 0.000 claims description 7
- 239000000284 extract Substances 0.000 claims description 7
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 7
- 241000196131 Dryopteris filix-mas Species 0.000 claims description 6
- 240000006688 Telosma cordata Species 0.000 claims description 6
- 235000017352 Telosma cordata Nutrition 0.000 claims description 6
- 241000196133 Dryopteris Species 0.000 claims description 5
- 241001673966 Magnolia officinalis Species 0.000 claims description 5
- 241001483116 Neopicrorhiza scrophulariiflora Species 0.000 claims description 5
- 235000013399 edible fruits Nutrition 0.000 claims description 5
- 238000002347 injection Methods 0.000 claims description 5
- 239000007924 injection Substances 0.000 claims description 5
- 238000003672 processing method Methods 0.000 claims description 5
- 235000008598 Paeonia lactiflora Nutrition 0.000 claims description 4
- 244000236658 Paeonia lactiflora Species 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 239000008517 radix Trichosanthis Substances 0.000 claims description 4
- 241001529821 Agastache Species 0.000 claims description 3
- 241001253169 Asystasia gangetica Species 0.000 claims description 3
- 206010051625 Conjunctival hyperaemia Diseases 0.000 claims description 3
- 235000002991 Coptis groenlandica Nutrition 0.000 claims description 3
- 240000000774 Cunila origanoides Species 0.000 claims description 3
- 235000018274 Cunila origanoides Nutrition 0.000 claims description 3
- 235000014866 Dictamnus albus Nutrition 0.000 claims description 3
- 208000014617 hemorrhoid Diseases 0.000 claims description 3
- 210000000214 mouth Anatomy 0.000 claims description 3
- 239000011505 plaster Substances 0.000 claims description 3
- 241000605447 Anemarrhena Species 0.000 claims description 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 2
- 235000017443 Hedysarum boreale Nutrition 0.000 claims description 2
- 235000007858 Hedysarum occidentale Nutrition 0.000 claims description 2
- 241000334160 Isatis Species 0.000 claims description 2
- 244000246386 Mentha pulegium Species 0.000 claims description 2
- 235000016257 Mentha pulegium Nutrition 0.000 claims description 2
- 235000004357 Mentha x piperita Nutrition 0.000 claims description 2
- 241000972673 Phellodendron amurense Species 0.000 claims description 2
- 240000004980 Rheum officinale Species 0.000 claims description 2
- 235000008081 Rheum officinale Nutrition 0.000 claims description 2
- 235000017276 Salvia Nutrition 0.000 claims description 2
- 240000007164 Salvia officinalis Species 0.000 claims description 2
- 241000207929 Scutellaria Species 0.000 claims description 2
- 241001671204 Stemona Species 0.000 claims description 2
- 229930191283 anemarrhena Natural products 0.000 claims description 2
- 210000000613 ear canal Anatomy 0.000 claims description 2
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims description 2
- 235000001050 hortel pimenta Nutrition 0.000 claims description 2
- 229940010454 licorice Drugs 0.000 claims description 2
- 244000277583 Terminalia catappa Species 0.000 claims 3
- 244000273928 Zingiber officinale Species 0.000 claims 3
- 244000299790 Rheum rhabarbarum Species 0.000 claims 2
- 206010050639 Allergic pharyngitis Diseases 0.000 claims 1
- 206010010744 Conjunctivitis allergic Diseases 0.000 claims 1
- 244000247747 Coptis groenlandica Species 0.000 claims 1
- 206010052140 Eye pruritus Diseases 0.000 claims 1
- 241000555682 Forsythia x intermedia Species 0.000 claims 1
- 206010017553 Furuncle Diseases 0.000 claims 1
- 241001135871 Gentiana scabra Species 0.000 claims 1
- 208000002205 allergic conjunctivitis Diseases 0.000 claims 1
- 208000024998 atopic conjunctivitis Diseases 0.000 claims 1
- 206010022000 influenza Diseases 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
- 229940100615 topical ointment Drugs 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
- 208000024891 symptom Diseases 0.000 abstract description 61
- 206010020751 Hypersensitivity Diseases 0.000 abstract description 23
- 230000007803 itching Effects 0.000 abstract description 21
- 208000026935 allergic disease Diseases 0.000 abstract description 18
- 230000007815 allergy Effects 0.000 abstract description 17
- 239000000739 antihistaminic agent Substances 0.000 abstract description 14
- 239000000203 mixture Substances 0.000 abstract description 14
- 230000001387 anti-histamine Effects 0.000 abstract description 10
- 230000003860 sleep quality Effects 0.000 abstract description 10
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 abstract description 9
- 206010003549 asthenia Diseases 0.000 abstract description 8
- 208000030961 allergic reaction Diseases 0.000 abstract description 6
- 206010062519 Poor quality sleep Diseases 0.000 abstract description 5
- 208000002399 aphthous stomatitis Diseases 0.000 abstract description 5
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 abstract description 4
- 208000007443 Neurasthenia Diseases 0.000 abstract description 4
- 201000007100 Pharyngitis Diseases 0.000 abstract description 4
- 206010010741 Conjunctivitis Diseases 0.000 abstract description 3
- 208000008350 Pruritus Vulvae Diseases 0.000 abstract description 3
- 206010056530 Vulvovaginal pruritus Diseases 0.000 abstract description 3
- 201000009961 allergic asthma Diseases 0.000 abstract description 3
- 208000006673 asthma Diseases 0.000 abstract description 3
- 208000020670 canker sore Diseases 0.000 abstract description 3
- 229940088597 hormone Drugs 0.000 abstract description 3
- 239000005556 hormone Substances 0.000 abstract description 3
- UCTWMZQNUQWSLP-UHFFFAOYSA-N Adrenaline Natural products CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 abstract description 2
- 229940102884 adrenalin Drugs 0.000 abstract description 2
- 201000005547 chronic conjunctivitis Diseases 0.000 abstract description 2
- 206010022998 Irritability Diseases 0.000 abstract 1
- 201000004484 acute conjunctivitis Diseases 0.000 abstract 1
- 208000016150 acute pharyngitis Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 26
- 238000011282 treatment Methods 0.000 description 25
- 208000010201 Exanthema Diseases 0.000 description 23
- 201000005884 exanthem Diseases 0.000 description 23
- 206010037844 rash Diseases 0.000 description 23
- 206010072757 chronic spontaneous urticaria Diseases 0.000 description 17
- JAUOIFJMECXRGI-UHFFFAOYSA-N Neoclaritin Chemical compound C=1C(Cl)=CC=C2C=1CCC1=CC=CN=C1C2=C1CCNCC1 JAUOIFJMECXRGI-UHFFFAOYSA-N 0.000 description 16
- 229960001271 desloratadine Drugs 0.000 description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 201000010099 disease Diseases 0.000 description 12
- 210000002784 stomach Anatomy 0.000 description 12
- 206010012735 Diarrhoea Diseases 0.000 description 11
- 241000234314 Zingiber Species 0.000 description 11
- 206010015150 Erythema Diseases 0.000 description 10
- 208000030949 chronic idiopathic urticaria Diseases 0.000 description 10
- 229960001971 ebastine Drugs 0.000 description 10
- MJJALKDDGIKVBE-UHFFFAOYSA-N ebastine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(=O)CCCN1CCC(OC(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 MJJALKDDGIKVBE-UHFFFAOYSA-N 0.000 description 10
- 231100000321 erythema Toxicity 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 206010000496 acne Diseases 0.000 description 9
- 208000017520 skin disease Diseases 0.000 description 9
- 208000003455 anaphylaxis Diseases 0.000 description 8
- 210000000689 upper leg Anatomy 0.000 description 8
- 206010002198 Anaphylactic reaction Diseases 0.000 description 7
- 210000002414 leg Anatomy 0.000 description 7
- ZKLPARSLTMPFCP-OAQYLSRUSA-N 2-[2-[4-[(R)-(4-chlorophenyl)-phenylmethyl]-1-piperazinyl]ethoxy]acetic acid Chemical compound C1CN(CCOCC(=O)O)CCN1[C@@H](C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-OAQYLSRUSA-N 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 241000628997 Flos Species 0.000 description 6
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 6
- 241000219061 Rheum Species 0.000 description 6
- 244000191422 Terminalia bellirica Species 0.000 description 6
- 239000002662 enteric coated tablet Substances 0.000 description 6
- 230000002458 infectious effect Effects 0.000 description 6
- 229960001508 levocetirizine Drugs 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- 231100000046 skin rash Toxicity 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 5
- 201000004681 Psoriasis Diseases 0.000 description 5
- 238000003287 bathing Methods 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 210000001035 gastrointestinal tract Anatomy 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 239000002574 poison Substances 0.000 description 5
- 230000007958 sleep Effects 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 230000009885 systemic effect Effects 0.000 description 5
- ZGDLVKWIZHHWIR-UHFFFAOYSA-N 4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]morpholine Chemical compound O1C(C)(C)C(C)(C)OB1C1=CC=C(N2CCOCC2)N=C1 ZGDLVKWIZHHWIR-UHFFFAOYSA-N 0.000 description 4
- YPELFRMCRYSPKZ-UHFFFAOYSA-N 4-amino-5-chloro-2-ethoxy-N-({4-[(4-fluorophenyl)methyl]morpholin-2-yl}methyl)benzamide Chemical compound CCOC1=CC(N)=C(Cl)C=C1C(=O)NCC1OCCN(CC=2C=CC(F)=CC=2)C1 YPELFRMCRYSPKZ-UHFFFAOYSA-N 0.000 description 4
- 208000028185 Angioedema Diseases 0.000 description 4
- 206010048768 Dermatosis Diseases 0.000 description 4
- FQISKWAFAHGMGT-SGJOWKDISA-M Methylprednisolone sodium succinate Chemical compound [Na+].C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)COC(=O)CCC([O-])=O)CC[C@H]21 FQISKWAFAHGMGT-SGJOWKDISA-M 0.000 description 4
- 208000012902 Nervous system disease Diseases 0.000 description 4
- HVRLZEKDTUEKQH-NOILCQHBSA-N Olopatadine hydrochloride Chemical compound Cl.C1OC2=CC=C(CC(O)=O)C=C2C(=C/CCN(C)C)\C2=CC=CC=C21 HVRLZEKDTUEKQH-NOILCQHBSA-N 0.000 description 4
- 229940125715 antihistaminic agent Drugs 0.000 description 4
- 235000006533 astragalus Nutrition 0.000 description 4
- 229960003957 dexamethasone Drugs 0.000 description 4
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 4
- 208000010643 digestive system disease Diseases 0.000 description 4
- 239000007919 dispersible tablet Substances 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 229960000334 methylprednisolone sodium succinate Drugs 0.000 description 4
- 229960004085 mosapride Drugs 0.000 description 4
- 210000000653 nervous system Anatomy 0.000 description 4
- 229960003139 olopatadine hydrochloride Drugs 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 229960001778 rabeprazole sodium Drugs 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 240000005528 Arctium lappa Species 0.000 description 3
- 235000003130 Arctium lappa Nutrition 0.000 description 3
- 235000008078 Arctium minus Nutrition 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 206010004053 Bacterial toxaemia Diseases 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 206010059866 Drug resistance Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 241000972672 Phellodendron Species 0.000 description 3
- 244000223014 Syzygium aromaticum Species 0.000 description 3
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 3
- 208000013222 Toxemia Diseases 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 229960001380 cimetidine Drugs 0.000 description 3
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 description 3
- 238000002648 combination therapy Methods 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 210000002249 digestive system Anatomy 0.000 description 3
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 description 3
- 230000008506 pathogenesis Effects 0.000 description 3
- 229960004618 prednisone Drugs 0.000 description 3
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 210000004706 scrotum Anatomy 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- LEZWWPYKPKIXLL-UHFFFAOYSA-N 1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound C1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 LEZWWPYKPKIXLL-UHFFFAOYSA-N 0.000 description 2
- VOBDXTSTTMAKHK-VHDCPBDGSA-N 3870-07-3 Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)COC(=O)C)[C@@]1(C)C[C@@H]2O VOBDXTSTTMAKHK-VHDCPBDGSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 241001061264 Astragalus Species 0.000 description 2
- 241000045403 Astragalus propinquus Species 0.000 description 2
- ZKLPARSLTMPFCP-UHFFFAOYSA-N Cetirizine Chemical compound C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-UHFFFAOYSA-N 0.000 description 2
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 2
- 241000218202 Coptis Species 0.000 description 2
- 244000301850 Cupressus sempervirens Species 0.000 description 2
- 241000218671 Ephedra Species 0.000 description 2
- 241000555712 Forsythia Species 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- ZCVMWBYGMWKGHF-UHFFFAOYSA-N Ketotifene Chemical compound C1CN(C)CCC1=C1C2=CC=CC=C2CC(=O)C2=C1C=CS2 ZCVMWBYGMWKGHF-UHFFFAOYSA-N 0.000 description 2
- 235000008708 Morus alba Nutrition 0.000 description 2
- 240000000249 Morus alba Species 0.000 description 2
- 241000717679 Mosla Species 0.000 description 2
- 235000003805 Musa ABB Group Nutrition 0.000 description 2
- 240000005561 Musa balbisiana Species 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 235000006484 Paeonia officinalis Nutrition 0.000 description 2
- 241001106477 Paeoniaceae Species 0.000 description 2
- 235000015266 Plantago major Nutrition 0.000 description 2
- 206010036772 Proctalgia Diseases 0.000 description 2
- 208000009544 Pruritus Ani Diseases 0.000 description 2
- 206010041349 Somnolence Diseases 0.000 description 2
- 102400000160 Thymopentin Human genes 0.000 description 2
- 101800001703 Thymopentin Proteins 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000002052 anaphylactic effect Effects 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 229940124350 antibacterial drug Drugs 0.000 description 2
- 210000000436 anus Anatomy 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 239000008338 calamine lotion Substances 0.000 description 2
- 229960001803 cetirizine Drugs 0.000 description 2
- 229960003291 chlorphenamine Drugs 0.000 description 2
- 230000009194 climbing Effects 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 229960003913 econazole Drugs 0.000 description 2
- 229960001347 fluocinolone acetonide Drugs 0.000 description 2
- FEBLZLNTKCEFIT-VSXGLTOVSA-N fluocinolone acetonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O FEBLZLNTKCEFIT-VSXGLTOVSA-N 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229960004958 ketotifen Drugs 0.000 description 2
- 229960003088 loratadine Drugs 0.000 description 2
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 description 2
- MQEUGMWHWPYFDD-UHFFFAOYSA-N magnesium;6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1h-benzimidazole Chemical compound [Mg].N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C MQEUGMWHWPYFDD-UHFFFAOYSA-N 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 229960003117 omeprazole magnesium Drugs 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000003071 parasitic effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 208000023504 respiratory system disease Diseases 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 238000006748 scratching Methods 0.000 description 2
- 230000002393 scratching effect Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000009897 systematic effect Effects 0.000 description 2
- 210000004233 talus Anatomy 0.000 description 2
- PSWFFKRAVBDQEG-YGQNSOCVSA-N thymopentin Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 PSWFFKRAVBDQEG-YGQNSOCVSA-N 0.000 description 2
- 229960004517 thymopentin Drugs 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 229940126673 western medicines Drugs 0.000 description 2
- 239000009571 yupingfeng Substances 0.000 description 2
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 description 2
- MFYSUUPKMDJYPF-UHFFFAOYSA-N 2-[(4-methyl-2-nitrophenyl)diazenyl]-3-oxo-n-phenylbutanamide Chemical compound C=1C=CC=CC=1NC(=O)C(C(=O)C)N=NC1=CC=C(C)C=C1[N+]([O-])=O MFYSUUPKMDJYPF-UHFFFAOYSA-N 0.000 description 1
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
- SODWJACROGQSMM-UHFFFAOYSA-N 5,6,7,8-tetrahydronaphthalen-1-amine Chemical compound C1CCCC2=C1C=CC=C2N SODWJACROGQSMM-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 235000007756 Akebia quinata Nutrition 0.000 description 1
- 240000008027 Akebia quinata Species 0.000 description 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 1
- 206010002199 Anaphylactic shock Diseases 0.000 description 1
- 241000382455 Angelica sinensis Species 0.000 description 1
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 description 1
- 235000003097 Artemisia absinthium Nutrition 0.000 description 1
- 240000001851 Artemisia dracunculus Species 0.000 description 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 235000006463 Brassica alba Nutrition 0.000 description 1
- 244000140786 Brassica hirta Species 0.000 description 1
- 235000011371 Brassica hirta Nutrition 0.000 description 1
- 241000202726 Bupleurum Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000035851 Chrysanthemum leucanthemum Species 0.000 description 1
- 241000931705 Cicada Species 0.000 description 1
- 241000007126 Codonopsis pilosula Species 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 244000008991 Curcuma longa Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 241000208688 Eucommia Species 0.000 description 1
- 241000735527 Eupatorium Species 0.000 description 1
- 241001289529 Fallopia multiflora Species 0.000 description 1
- 206010016326 Feeling cold Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 244000111489 Gardenia augusta Species 0.000 description 1
- 235000018958 Gardenia augusta Nutrition 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 241001513907 Heracleum hemsleyanum Species 0.000 description 1
- 235000013717 Houttuynia Nutrition 0.000 description 1
- 240000000691 Houttuynia cordata Species 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010020852 Hypertonia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 241001598107 Imperata Species 0.000 description 1
- 208000009481 Laryngeal Edema Diseases 0.000 description 1
- 206010023845 Laryngeal oedema Diseases 0.000 description 1
- 244000207740 Lemna minor Species 0.000 description 1
- 235000006439 Lemna minor Nutrition 0.000 description 1
- 241001071917 Lithospermum Species 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010033551 Palmar erythema Diseases 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 244000274050 Platycodon grandiflorum Species 0.000 description 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- 235000001855 Portulaca oleracea Nutrition 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- 235000003713 Rhodiola rosea Nutrition 0.000 description 1
- 244000042430 Rhodiola rosea Species 0.000 description 1
- 241001162994 Rugosus Species 0.000 description 1
- 235000008422 Schisandra chinensis Nutrition 0.000 description 1
- 240000006079 Schisandra chinensis Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 241000304432 Sedum sarmentosum Species 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- 241000219784 Sophora Species 0.000 description 1
- 241000246044 Sophora flavescens Species 0.000 description 1
- 241000913745 Spatholobus Species 0.000 description 1
- 240000007641 Spergula rubra Species 0.000 description 1
- 244000290970 Tetrapanax papyrifer Species 0.000 description 1
- 208000024799 Thyroid disease Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241001533104 Tribulus terrestris Species 0.000 description 1
- 240000007098 Vigna angularis Species 0.000 description 1
- 241000331449 Vincetoxicum pycnostelma Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000001138 artemisia absinthium Substances 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 208000024330 bloating Diseases 0.000 description 1
- 229960004494 calcium gluconate Drugs 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- 239000004227 calcium gluconate Substances 0.000 description 1
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- SOYKEARSMXGVTM-UHFFFAOYSA-N chlorphenamine Chemical compound C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 SOYKEARSMXGVTM-UHFFFAOYSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- CEYULKASIQJZGP-UHFFFAOYSA-L disodium;2-(carboxymethyl)-2-hydroxybutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O CEYULKASIQJZGP-UHFFFAOYSA-L 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 229960003645 econazole nitrate Drugs 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 229960003630 ketotifen fumarate Drugs 0.000 description 1
- YNQQEYBLVYAWNX-WLHGVMLRSA-N ketotifen fumarate Chemical compound OC(=O)\C=C\C(O)=O.C1CN(C)CCC1=C1C2=CC=CC=C2CC(=O)C2=C1C=CS2 YNQQEYBLVYAWNX-WLHGVMLRSA-N 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000001640 nerve ending Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229960000470 omalizumab Drugs 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000009806 pulsatillae Substances 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- 229960001520 ranitidine hydrochloride Drugs 0.000 description 1
- GGWBHVILAJZWKJ-KJEVSKRMSA-N ranitidine hydrochloride Chemical compound [H+].[Cl-].[O-][N+](=O)\C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 GGWBHVILAJZWKJ-KJEVSKRMSA-N 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000037321 sleepiness Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 229960002117 triamcinolone acetonide Drugs 0.000 description 1
- YNDXUCZADRHECN-JNQJZLCISA-N triamcinolone acetonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O YNDXUCZADRHECN-JNQJZLCISA-N 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
- A61K36/515—Gentiana
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/532—Agastache, e.g. giant hyssop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/538—Schizonepeta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
- A61K36/855—Clerodendrum, e.g. glorybower
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/86—Violaceae (Violet family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8964—Anemarrhena
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/904—Stemonaceae (Stemona family), e.g. croomia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
发明名称:治疗荨麻疹、湿疹、过敏/变态反应体质的中药组方。技术领域:医学皮肤病/变态反应科、中医/中药学、微生物学。通过内服、外涂中药组方Ⅰ、中药组方Ⅱ或其混合调整组方,实现控制、逐步改善并治愈急慢性荨麻疹、急慢性湿疹、过敏(变态反应)体质及其并发症:急慢性结膜炎、急慢性咽炎、口疮溃疡、慢性(溃疡性)肠胃炎、肛门瘙痒、阴痒、过敏性鼻炎、过敏性支气管炎/哮喘、睡眠质量差、神经衰弱、精神亢奋、体虚乏力、关节酸痛及肌肉疼痛,抑制并治愈不明原因皮肤剧烈剧痒。急性、重症荨麻疹、湿疹需联合抗组胺药、激素、肾上腺素等控制过敏症状,以期做到标本兼治。
Description
技术领域
医学:皮肤病/变态反应科、中医/中药学、微生物学。
背景技术
荨麻疹、湿疹、过敏(变态反应)体质病症发病的根本原因,全球医学界尚无定论。西医治疗该病重在干预过敏反应发生的过程,多用抗组胺药、免疫调节药(如奥马珠单抗)及激素类药(如地塞米松、氢化可的松),其中抗组胺药使用最为广泛,此疗法在控制急性荨麻疹、急性湿疹皮肤症状方面疗效显著,但对于过敏(变态反应)体质和慢性荨麻疹、慢性湿疹患者来说,只能控制症状不能治愈,而且治愈的急性荨麻疹、急性湿疹患者,不能根除发生过敏的根本诱因,存在使急性荨麻疹、急性湿疹转化为慢性荨麻疹、慢性湿疹及过敏体质的风险。中医治疗荨麻疹及湿疹具备标本兼治的优势,治愈的急性荨麻疹(急性湿疹)基本不存在转换为慢性荨麻疹(慢性湿疹)的可能,特别是在治疗慢性荨麻疹、慢性湿疹和过敏(变态反应)体质方面,中药疗效显著,能够控制症状的抗药周期长,具备治愈慢性荨麻疹、慢性湿疹和过敏(变态反应)体质的潜质,不幸的是,在治疗荨麻疹、湿疹和过敏中,中药的普及率和使用频率远远低于抗组胺药。而且中医对于荨麻疹、湿疹及过敏的理解为“瘾疹”、“风邪”、“湿疮”,病机的认知模糊,以此为理论基础的治疗,难以达到治愈的目的。
发明概述
自2010年至2015年9月,在对本人家族传染性慢性自发性重度荨麻疹(过敏体质)持续治疗过程中,曾先后用过内服药:皮肤病血毒丸-同仁堂、玉屏风胶囊、润燥止痒胶囊、百癣夏塔热片、八珍颗粒、氯雷他定片、地氯雷他定分散片、枸地氯雷他定片、西替利嗪、盐酸左西替利嗪、西米替丁片、扑尔敏、酮替芬、泼尼松片、复合维生素B片等内服药,同时皮疹外涂过氟轻松软膏、醋酸曲安奈德益康唑乳膏、地塞米松软膏、丹皮酚软膏、炉甘石洗剂等外涂药,以上内服药均采用联合疗法,其中以皮肤病血毒丸+枸地氯雷他定片(或地氯雷他定分散片)+盐酸左西替利嗪片联合治疗,以及百癣夏塔热片+枸地氯雷他定片(或地氯雷他定分散片)+盐酸左西替利嗪片联合治疗效果最好,此疗程本人重度慢性自发性荨麻疹(过敏体质)症状有一定程度减轻,但始终未能治愈,且控制症状效果越来越差。
在过去5年多慢性自发性荨麻疹(过敏体质)的持续治疗过程中,作者发现中成药:皮肤病血毒丸-同仁堂及百癣夏塔热片,在控制皮肤瘙痒、目赤目痒、阴囊瘙痒、口疮、耳道内瘙痒、慢性消化系统及慢性神经系统疾病等并发症中起到决定性作用,于是自2015年9月份开始尝试中草药组方治疗,2015年11 月份后开始采用中药颗粒剂组方。截至2018年11月,采用过的中草药(颗粒剂)种类有:玉米须、地骨皮、白茅根、知母、土茯苓、(麸)炒白术、黄芪、百部、黄柏、苦参、防风、荆芥、荷叶、白鲜皮、金银花、紫草、桑叶、(麸) 炒薏苡仁、泽泻、豆蔻、菊花、地肤子、车前草、(盐)车前子、丹参、徐长卿、牡丹皮、桂枝、党参、栀子、赤芍、蝉蜕、红景天、炒谷芽、炒鸡内金、川牛膝、(生)石膏、蜂房、木通、苍术、生地黄、当归、甘草、炒牛蒡子等四十多种,每付中草药组方由12种至19种不等品类组成。中草药组方能够重新控制本人的慢性自发性荨麻疹症状,且逐步进一步改善本人的过敏体质状况。2016 年4月至5月,曾尝试内服中成药荨麻疹丸,同时每月注射一次力尔肽(注射用胸腺五肽)调节机体免疫力,与内服中药颗粒剂组方相比,疗效并不突出,而且荨麻疹丸内服后,给胃肠道造成极大的不适感,试用两个月后该疗法停止。
2018年12月份以后,开始尝试新的中药(颗粒剂)品种,原常用品种药效变差,或者说在持续止痒、抗过敏、控制目赤目痒、阴囊瘙痒、口疮、耳道内瘙痒、慢性消化系统及慢性神经系统疾病等并发症方面收效甚微。截止2022年 3月份,新采用过的中药(颗粒剂)种类有:炒苦杏仁、干姜、姜黄、陈皮、炒僵蚕、(蜜)麻黄、浮萍、川芎、黄芩、紫花地丁、皂角刺、白芷、忍冬藤、独活、连翘、白芍、龙胆草、(姜)厚朴、厚朴花、香薷、黄连、胡黄连、天花粉、炒决明子、蒲公英、(炒)蒺藜、大青叶、(炒)白芥子、桔梗、(醋)五味子、乌梅、柴胡、银柴胡、(制)何首乌、通草、茵陈、(盐)杜仲、羌活、诃子、鱼腥草、青蒿、薄荷、紫苏叶、绵马贯众、射干、野菊花、辛夷、茯苓、鸡血藤、石决明、蛇蜕、丁香、山茱萸、生姜、藿香、(熟)大黄、千里光、白头翁等五十多种,同时继续沿用之前部分种类中药颗粒剂:甘草、(盐)知母、牡丹皮、(麸)炒白术、黄芪、苦参、荆芥、防风、桂枝、白鲜皮、桑叶、丹参、赤芍、百部、黄柏、金银花、(炒)牛蒡子、菊花、地肤子等。
在参阅国内众多中医学专家曾用或推荐的验方、经典组方、中药品类等,共筛选出以上近百种中草药品类,并经过本人反复试用试验,从3至4种(约相当于饮片90g至110g)品类组方,到18至21种(约相当于饮片180g至210g) 品类组方,最后到26种(约相当于饮片260g)品类组方,并据此得到颇具疗效的三十几味中草药品类,取其中18至20种品类(约相当于饮片180g至200g) 组成中草药组方,其疗效最佳且副作用相对最小。截止2022年3月,本人家族传染性重度慢性自发性荨麻疹(过敏体质)已痊愈。
作者根据10多年不间断对家族性传染、寒冷型、慢性自发性荨麻疹的治疗,通过治疗手段和结果,发现过敏(变态反应)体质、荨麻疹、湿疹的根本病因在于:细菌、真菌、病毒等微生物侵入机体,在宿主体内适应、生存并大量繁殖,与宿主竞争性摄取营养物质,破坏宿主组织、器官及神经元,同时新陈代谢排到宿主体液内的有毒物质进一步危害宿主的组织、器官及神经元,如此持续不断,造成宿主机体的过敏反应、剧烈瘙痒及各种并发疾病。
当感染寄生的微生物为一到两种且短时间内大量繁殖时,宿主表现为突发性、急性荨麻疹(或急性湿疹)。当感染寄生的微生物为多种,且在不同时间段内分别侵入宿主体内,适应、生存并逐渐大量繁殖,此时宿主机体表现出过敏(变态反应)体质、慢性荨麻疹、慢性湿疹。所以治疗过敏、荨麻疹及湿疹的根本手段在于抗微生物,抑制其生长、繁殖,杀灭病原体,净化宿主体液。虽然寄生的致病微生物种类很难查出其类别,但是中药中很多广谱抗菌药,对多种类型微生物起到不同的抑制、抵抗甚至杀灭作用,因此可以采用中药抗菌药组方形式,针对性的治疗该病症。传统中医在治疗过敏体质、慢性荨麻疹、慢性湿疹中采用的祛风除湿、清热解毒疗法,正好达到了抗菌消炎的作用,所以疗效显著。但是传统中医对过敏的认识囿于“风邪”、“瘾疹”、“湿疮”,对于引发过敏的微生物的数量巨大且变异能力强从根本上认识不清,所以对于治疗过程中抗药性的认知不清,没有本质正确的治疗理念做指导,难以维持真正有效的治疗手段,所以难以根治过敏体质及慢性荨麻疹、慢性湿疹。
问题的解决方案
排除肿瘤、严重肝肾疾病、甲状腺疾病引发荨麻疹、湿疹、过敏(变态反应)因素。辨证确诊为荨麻疹(不分类型)、过敏体质、湿疹。
长期伴有消化系统和神经系统疾病者,如长期腹泻、慢性咽炎、口疮溃疡、慢性(溃疡性)肠胃炎、肛门瘙痒、阴痒、睡眠质量差、神经衰弱、精神亢奋、体虚乏力等症状,可以采用中药组方:甘草10g、薄荷6g、丹参10g、炒白术 10g、诃子10g、黄芩10g、黄连6g、连翘10g、紫苏叶10g、香薷10g、百部10g、白芍12g、绵马贯众10g、盐知母12g、白鲜皮10g、白芷10g、蒲公英10、丁香10g、山茱萸10g、紫花地丁15g。服用该组方可以控制瘙痒及机体过敏反应,缓解腹泻,缓解因全身过敏或瘙痒造成的精神亢奋,同时有助于晚上高质量睡眠,且该组方在持续用药一年内基本不会产生抗药性。
长期伴有呼吸系统疾病和神经系统疾病者,如过敏性鼻炎、过敏性支气管炎/哮喘、睡眠质量差、神经衰弱、精神亢奋、体虚乏力,从抗菌、抗变态反应、镇静、调节免疫系统着手选药,如组方:甘草10g、薄荷12g、丹参10g、龙胆 6g、青蒿15g、黄芩10g、黄连6g、连翘10g、紫苏叶10g、姜厚朴12g、天花粉15g、千里光15g、黄柏12g、金银花10g、大青叶15g、熟大黄6g、胡黄连 3g、生姜10g、藿香10g,服用该组方可以控制瘙痒及过敏反应,抑制过敏性鼻炎、过敏性支气管炎/哮喘,缓解因全身过敏或瘙痒造成的精神亢奋,同时有助于晚上有高质量睡眠。
兼具伴有呼吸系统、消化系统和神经系统疾病者,慢性结膜炎、慢性咽炎、口疮溃疡、慢性(溃疡性)肠胃炎、肛门瘙痒、阴痒、过敏性鼻炎、过敏性支气管炎/哮喘、睡眠质量差、神经衰弱、精神亢奋、体虚乏力等,可以从以下中草药种类中选择组方:黄芩3-9g、黄连1.5-8g、连翘6-15g、(姜)厚朴3-10g、紫花地丁10-30g、炒白术3-15g、白芷3-10g、白芍5-12g(15-30g)、知母6-12g、天花粉9-15g、甘草10g、炒决明子6-30g、百部3-10g、紫苏叶5-10g、黄柏 3-9g、青蒿6-15g(20-40g)、大青叶10-15g、绵马贯众5-15g、丹参5-15g、薄荷3-6g、千里光15-30g、白头翁15-30g、香薷3-9g、蒲公英10-30g(60g)、金银花10-20g、射干5-10g、牡丹皮6-9g、辛夷3-10g、大黄3-12g、生姜3-10g、诃子3-6g、白鲜皮6-15g、山茱萸5-10g、菊花10-15g、川芎3-10g、龙胆3-6g、荆芥3-10g、胡黄连6-12g、藿香6-10g。
急性荨麻疹、突发性重症过敏,如过敏性休克、喉头水肿,过敏引起的高血压、低血压、昏厥等症状应先控制过敏症状,再利用中药组方根除过敏源:二代抗组胺药联合中药组方,或者系统性、分阶段联合糖皮质激素+二代抗组胺药+中药组方,或者系统性、分阶段联合肾上腺素+二代抗组胺药+中药组方。
发明的最佳实施方式
中药组方Ⅰ成分:黄芩、黄连、连翘、紫苏叶、厚朴、白术、白芷、白芍、决明子、黄柏、百部、青蒿、知母、天花粉、甘草、薄荷、绵马贯众、丹参、紫花地丁、大青叶20种中草药的科学提取物。以上20种中草药国家中医药管理局《中华本草》(上海科学技术出版社,1999.9)的推荐剂量是:黄芩3-9g、黄连1.5-8g、连翘6-15g、紫苏叶5-10g、厚朴3-10g、白术3-15g、白芷3-10g、白芍5-12g(15-30g)、决明子6-30g、黄柏3-9g、百部3-10g、青蒿6-15g(20-40g)、知母6-12g、天花粉9-15g、甘草10g、薄荷3-6g、绵马贯众5-15g、丹参5-15g、紫花地丁10-30g、大青叶10-15g。
参照国家中医药管理局《中华本草》(上海科学技术出版社,1999.9)对上述20种成分的推荐剂量和炮制方法,进一步确定各成分及其含量为:黄芩 9g-10g、黄连6-8g、连翘10-12g、紫苏叶10g、姜厚朴10-12g、炒白术10g、白芷10-12g、白芍10-12g、炒决明子10-15g、黄柏9-12g、百部10g、青蒿10-12g、盐知母10-12g、天花粉10-12g、甘草9-10g、薄荷6-12g、绵马贯众10-12g、丹参8-10g、紫花地丁10-15g、大青叶10-15g。用该20种成分的科学提取物组成中药组方Ⅰ,制成内服丸剂、散剂或胶囊等内服药;同时用该20种成分的提取物制成外涂药液、药膏或药贴等外涂、外敷用药,配合内服药在皮肤瘙痒剧烈的地方用以外涂、外敷等。
内服+外涂该组方,可以迅速控制各种荨麻疹、各型湿疹、过敏/变态反应症状及许多不明原因皮肤剧烈瘙痒病症,持续用药可以彻底治愈上述症状。在前期内服该组方,如出现荨麻疹、湿疹、过敏及皮肤瘙痒加重的情况,可以联合内服抗组胺药,以达到标本兼治的目的。
发明的实施方式
中药组方Ⅱ:科学提取甘草、薄荷、大黄、香薷、蒲公英、千里光、白头翁、辛夷、射干、川芎、金银花、诃子、荆芥、生姜、牡丹皮、白鲜皮、菊花、龙胆草、胡黄连、藿香、山茱萸21种中草药有效成分,各成分按国家中医药管理局《中华本草》(上海科学技术出版社,1999.9)推荐剂量:甘草10g、薄荷 3-6g、千里光15-30g、白头翁15-30g、香薷3-9g、蒲公英10-30g(60g)、金银花10-20g、射干5-10g、牡丹皮6-9g、辛夷3-10g、大黄3-12g、生姜3-10g、诃子3-6g、白鲜皮6-15g、山茱萸5-10g、菊花10-15g、川芎3-10g、龙胆3-6g、荆芥3-10g、胡黄连6-12g、藿香6-10g。
参照国家中医药管理局《中华本草》(上海科学技术出版社,1999.9)对上述21种成分的推荐剂量和炮制方法,进一步确定各成分及其含量为:甘草9-10g、薄荷6-12g、千里光15-20g、白头翁15-20g、香薷9-10g、蒲公英10-15g、金银花10-15g、射干9-10g、牡丹皮9-10g、辛夷9-10g、熟大黄5-6g、生姜9-10g、诃子6-10g、白鲜皮10-12g、山茱萸9-10g、丁香10g、菊花10-12g、川芎6-10g、龙胆5-6g、荆芥9-10g、胡黄连3g、藿香9-10g,科学提取各成分有效成分并组成中药组方Ⅱ,制成内服丸剂或胶囊作内服药;同时用各成分的科学提取物组成中药组方Ⅱ并制成外涂药液或药膏,配合内服药在皮肤瘙痒剧烈的地方用以外涂。
内服+外涂该组方,可以迅速控制各种荨麻疹、各型湿疹、过敏/变态反应症状及许多不明原因皮肤剧烈瘙痒病症,持续用药可以彻底治愈这些病症。在前期内服该组方,如出现荨麻疹、湿疹、过敏及皮肤瘙痒加重的情况,可以联合内服抗组胺药,以达到标本兼治的目的。
工业实用性
控制慢性自发性荨麻疹、慢性荨麻疹、急性荨麻疹、各型湿疹、过敏/变态反应体质、许多不明原因剧烈瘙痒症状的同时,逐步治愈这些病症。
实施案例患者1:家族传染性(遗传型)慢性自发性荨麻疹,男,39岁。
自2010年至2015年9月,曾先后用过内服药:皮肤病血毒丸-同仁堂、玉屏风胶囊、润燥止痒胶囊、百癣夏塔热片、八珍颗粒、氯雷他定片、地氯雷他定分散片、枸地氯雷他定片、西替利嗪、盐酸左西替利嗪、西米替丁片、扑尔敏、酮替芬、泼尼松片、复合维生素B片等内服药,同时皮疹外涂过氟轻松软膏、醋酸曲安奈德益康唑乳膏、地塞米松软膏、丹皮酚软膏、炉甘石洗剂等外涂药,以上内服药品均采用联合疗法,如枸地氯雷他定片+左西替利嗪片+润燥止痒胶囊联合用药;枸地氯雷他定片+皮肤病血毒丸联合用药。在用该疗法治疗的5-6年间,前期控制效果相对较好,重度慢性自发性荨麻疹(过敏体质)症状有一定程度减轻,但始终未能完全控制住皮肤瘙痒及其他并发症状,也未能治愈慢性荨麻疹,且控制症状效果越来越差。在此治疗过程中,发现中成药皮肤病血毒丸-同仁堂及百癣夏塔热片在控制荨麻疹症状及改善过敏体质中起到决定作用。
自2015年11月份至2022年3月份,采用中药颗粒剂组方治疗本人的重症慢性自发性荨麻疹,在参阅国内众多中医学专家曾用或推荐的验方、经典组方、中药品类等,共筛选出近百种中草药品类,经过反复试用试验,从3至4种(约相当于饮片90g至110g)品类组方,到18至21种(约相当于饮片180g至210g) 品类组方,最后到26种(约相当于饮片260g)品类组方,并据此得到颇具疗效的三十几味中草药品类,组成疗效最佳且副作用相对最小的中药组方Ⅰ及中药组方Ⅱ。用中药组方Ⅰ及中药组方Ⅱ(或两组方部分成分交叉调换),2021年1月份之后,经过近1年的持续治疗,彻底治愈患者家族传染性(遗传型)慢性自发性重度荨麻疹(过敏体质)。
患者2:家族传染性(遗传型)慢性自发性荨麻疹,女,54岁。
患者1的姑姑,患者自小全身重度瘙痒,病程五十多年,荨麻疹症状常年存在,瘙痒时挠抓处出现深红色抓痕,而且剧烈瘙痒难以缓解。瘙痒过后,皮肤恢复正常,秋冬季症状加重。辨证为家族传染性重症自发性寒冷型荨麻疹。
2014年2月开始内服中成药皮肤病血毒丸-同仁堂,偶尔联合内服盐酸左西替利嗪片和地氯雷他定分散片控制过敏症状,疗程半年多,疗效显著,皮肤瘙痒症状有较大程度的改善,但未根除。2021年2月,荨麻疹复发后内服患者1 常用的两个中药组方:中药组方Ⅰ及中药组方Ⅱ(颗粒剂调整方),其中组方Ⅰ去黄芩、连翘、绵马贯众;组方Ⅱ去千里光、白头翁、辛夷、射干、丁香、藿香、山茱萸、龙胆,加黄芩、连翘、桂枝、苦参、炒牛蒡子。两组方各5付,每天1付,300ml温开水充分溶解,早晚各半付。每种组方内服均能控制荨麻疹症状。10付药内服后,复发的荨麻疹症状完全消失。停药后5天回访,荨麻疹症状没再出现。停药后10天时,患者所在地天气突然转冷并降下大雪,回访患者荨麻疹症状没再出现,包括夜间睡觉也没有瘙痒的感觉。停药后20天,回访患者荨麻疹症状没再出现。初步判断该患者荨麻疹基本治愈。
患者3:慢性自发性荨麻疹,男,47岁。
2021年七八月份开始,无明显诱因发作重度荨麻疹,全身红斑,手掌上红疹,部分红斑大面积出现,剧烈瘙痒,伴发慢性消化道疾病,胃发胀发堵并间断发作剧烈疼痛,腹痛伴随腹泻,阴囊瘙痒,肛门瘙痒、疼痛,有内、外痔疮表现,口腔周围上火起脓包,夜间皮肤瘙痒严重,睡眠质量差,食欲不振。2021 年10月份开始到蚌埠市第三人民医院治疗,门诊诊断“急性荨麻疹”,给予静脉滴注甲泼尼龙琥珀酸钠(40mg/支)80-120mg抗炎,内服地氯雷他定、依巴斯汀片抗过敏,内服枸橼酸莫沙必利片、雷贝拉唑钠肠溶片护胃。因始终不能控制好病症,于2021年10月10日住院治疗,住院期间静脉滴注甲泼尼龙琥珀酸钠(40mg/支)40mg每天一次抗炎、维生素C(1g/支)3g每天一次、葡萄糖酸钙(10ml:1g)、西咪替丁注射液(2ml:0.2g/支)200mg每天一次,同时内服枸地氯雷他定片、依巴斯汀片、富马酸酮替芬片抗过敏,内服枸橼酸莫沙必利片、雷贝拉唑钠肠溶片护胃,皮肤皮疹先后外涂丹皮酚软膏、曲安奈德益康唑乳膏。到10月28日出院时,全身剧烈瘙痒缓解,躯干及四肢泛发的红斑较入院时明显减少,但全身瘙痒仍很明显,夜间睡眠质量、食欲依然很差,仍然需要每天静脉滴注甲泼尼龙琥珀酸钠、维生素C等抗炎,同时联合内服枸地氯雷他定片、依巴斯汀片抗过敏,内服枸橼酸莫沙必利片或者雷贝拉唑钠肠溶片护胃,才能缓解胃部及肛门间断发作的剧烈疼痛。
自2022年1月19日开始,在静脉滴注甲泼尼龙琥珀酸钠(40mg/支)40mg 每天一次抗炎、维生素C(1g/支)3g每天一次,内服抗组胺、护胃药基础上,开始内服中药组方,每天一付。抗组胺药先后用过枸地氯雷他定片、依巴斯汀片、盐酸奥洛他定片、盐酸雷尼替丁胶囊,护胃药先后用过枸橼酸莫沙必利片、雷贝拉唑钠肠溶片、奥美拉唑镁肠溶片,中药组方先后用了中药组方Ⅰ、中药组方Ⅱ、组方Ⅰ与组方Ⅱ的混合调整方。2022年1月29日停止静脉注射,先后加用激素泼尼松片、地塞米松片抗炎。2月15日停止内服激素,仅内服中药组方综合抗菌、盐酸奥洛他定片抗组胺、奥美拉唑镁肠溶片护胃。2月26日,停止内服护胃药,减量内服盐酸奥洛他定片(由原来早、晚各1片/天,减量为1 片/天),仅常规内服中药组方Ⅰ。3月1日,全身皮肤全部恢复健康状态,没有留下任何斑痕,胃部发胀发堵的感觉消失,疼痛感已全部消失,恢复痊愈。仍坚持内服中药组方Ⅰ,辅助内服抗组胺药盐酸奥洛他定片1片/天,用以控制全身偶发的轻度瘙痒及伴发的肛门瘙痒,同时巩固治疗结果。自从在西药治疗该患者慢性自发性荨麻疹基础上,加入内服中药组方Ⅰ(或组方Ⅱ、或其调整组方),患者胃部发胀发堵、胃部及肛门疼痛、肛门瘙痒、全身红斑、手掌红疹及全身瘙痒症状每天都在明显减轻,夜晚睡眠质量一步步提高,尽管期间症状有反复,但总体明显向着痊愈发展,比单用西药对症状控制效果好很多。
患者4:获得性慢性自发性荨麻疹(重症皮肤划痕症)、手部湿疹,男,40岁。
2020年5月16日,患者自述患荨麻疹1年多,无诱因而发生,发作时大腿内侧肌肉瘙痒剧烈,洗澡时不敢揉搓大腿内侧皮肤,否则摩擦部位即刻出现红斑并剧烈瘙痒,洗澡后瘙痒加重,伴红斑,搔抓后表皮溃疡,现血红色。给患者内服中药组方Ⅰ及中药组方Ⅱ成分交叉调整方颗粒剂。中药组方Ⅰ(成分调整)共5付,每天1付,300ml左右温开水充分溶解,早晚各半付或者早、中、晚分三次内服,同时皮肤瘙痒剧烈处组方水溶液外涂。第一付内服后,大腿内侧肌肉瘙痒似有加重,但全身神经放松镇静,精神困倦,当晚睡眠质量很高。第二付后,大腿内侧肌肉瘙痒症状大大改善,洗澡后不再惯常性瘙痒。5付后症状消失,洗澡后大腿内侧肌肉也没再瘙痒。接着内服中药组方Ⅱ(成分调整),共3付,每天1付,300ml左右温开水充分溶解,早晚各半付或者早、中、晚分三次内服。从开始内服中药组方Ⅰ,以及之后内服中药组方Ⅱ,患者都会感觉整天困倦,药物神经镇定作用非常强,说明其机体神经系统完全松弛下来。洗澡时揉搓皮肤,瘙痒也没再发生。
2020年9月11日,患者再次问诊,说因工作中必须戴塑胶防护手套,长期造成双手十指起满米粒大小疙瘩,剧烈瘙痒,刺破疙瘩则流出水液,十指肿胀疼痛,部分开裂,皮肤干燥脱皮。据症状判断乃手部湿疹。因湿疹和荨麻疹发病机理类似,二者发病根源同出自机体微生物病原体感染。于是给于内服中药组方Ⅰ(颗粒剂),共10付,每天1付,300ml左右温开水充分溶解,早、晚各半付,皮肤瘙痒严重时同时可外涂。内服3付后,十指肿胀感缓解,皮肤开裂减轻,瘙痒减轻。第4至第5付用完后,出现轻度腹泻,同时双手十指肿胀及疼痛感消失,瘙痒消失,皮肤开裂在慢慢愈合,皮肤干燥缓解,但仍然脱皮。第7至第8付,服过药后胃部轻度不适,胃反酸发苦,口发苦,手部除皮肤仍显干燥、脱皮外,其他症状消失。
患者5:慢性湿疹,女,35岁
2021年8月27日,患者因双腿重度湿疹到蚌埠市中医院中医科就医。每年立夏患者双腿慢性湿疹自行发作,布满丘疹,丘疹周围皮疹泛红,红色皮疹形状不规则,剧烈瘙痒,夜间尤其严重,睡眠质量特别差,进入秋季,湿疹自行消退。之前患者慢性湿疹发作时也内服中药汤剂治疗,控制瘙痒效果明显,但所用组方会给消化系统带来严重负担,造成严重腹泻,且后来该组方控制瘙痒的效果逐渐变差。中医科辩证给处方:麸炒苍术8g、黄柏10g、姜竹茹10g、姜厚朴8g、薏苡仁10g、炒谷芽15g、炒麦芽15g、麸炒枳壳8g、地肤子10g、垂盆草10g、佩兰8g、玉米须8g共7付12味中草药,每日1付,早、晚各半付,水煎服。患者内服该处方后,双腿湿疹仍然瘙痒剧烈,夜不能眠,用药3付而后停止内服。
8月31日开始,患者内服+外涂患者1所用中药组方Ⅰ调整方(颗粒剂):去丹参、大青叶、白芷,加中药组方Ⅱ所含成分:川芎6g、金银花10g、蒲公英10g,每天1付,早晚各半付,300ml温开水冲服。内服中药组方Ⅰ(调整方) 后,双腿湿疹剧烈瘙痒很快缓解,但外涂中药组方Ⅰ(调整方)药液到双腿皮疹上,会造成皮疹短时间内瘙痒加剧。(分析:外涂中药液至皮疹,刺激皮疹病原体,使没有被抑制和杀灭的病原体活动加剧,造成皮疹短时间内瘙痒加剧。) 4付药后,患者双腿湿疹症状明显减轻,剧烈瘙痒变得轻微,双腿皮疹及瘙痒时抓烂的皮肤结痂。之后患者内服中药组方Ⅰ时发生腹泻,因腹泻并不严重,建议患者继续服药。因内服该中药组方,会使患者身体排毒加剧,一定程度的腹泻有益于患者湿疹的快速治愈,所以没有改变患者的用药情况。
患者6:急性荨麻疹,男,37岁。
2020年8月,患者自述前一天到水稻田喷洒农药,回到家后右边腰部开始出现大小不一的疙瘩,疙瘩连接成一片,疙瘩周边是鲜红的过敏皮肤,剧烈瘙痒,十分难忍。(该患者为过敏体质,自述晚上睡觉时,后背经常瘙痒)
选取中药组方Ⅰ及中药组方Ⅱ中部分成分:天花粉10g,白芷12g,蒲公英 10g,黄芩10g,白芍10g,黄柏10g,桂枝6g,连翘10g,盐知母10g,甘草9g,炒决明子10g,白术10g,共12味,组方(中药颗粒剂)4付,内服同时外涂皮疹处。内服一天2次,每天1付,200ml温开水充分溶解,早、晚各半付,外涂皮疹一天至少3~4次。内服一付药后,同时剩余少量外涂皮疹处,剧烈瘙痒症状消失,过敏起疙瘩的皮疹和水肿周边呈鲜红色的皮肤转为轻微刺痒,接着内服和外涂该组方,症状逐步减轻。4付药后,皮疹水肿消失,瘙痒完全消失,过敏呈鲜红色的皮肤转变为红色的绿豆大小的丘疹,因患者嫌药太苦没再继续服药,而后过敏症状逐步自行消失。
患者7:获得性慢性自发性荨麻疹,男,19岁。
患者常年后背、大腿内侧、阴囊处、肛门瘙痒严重,无故发作,其他部位泛发且发无定处,天气变化前、气候变化过程中,瘙痒尤其剧烈,夜间瘙痒严重,病程多年。其父母及其他直系亲属均无过敏性疾病。
2020年4月12日开始,内服中药组方3(中药颗粒剂)(取中药组方Ⅰ部分成分):姜厚朴12g,白芷12g,白术10g,黄芩10g,白芍10g,黄芪10g,黄连6g,桂枝6g,连翘10g,盐知母10g,甘草9g,炒决明子10g,共15付12 味药,每天1付,200ml温开水充分溶解,早晚各半付。
而后内服中药组方4(中药颗粒剂)(取中药组方Ⅰ、组方Ⅱ中部分成分):蒲公英10g,白术10g,黄芩10g,白芍10g,黄芪10g,桂枝6g,连翘10g,盐知母10g,甘草9g,天花粉10g,大黄6g,白芷6g,共20付12味药,内服方法同组方3。内服后腹泻(组方含大黄6g,用以排毒)。
加上之前曾内服皮肤病血毒丸-同仁堂治疗慢性荨麻疹症状,比较组方3、组方4和皮肤病血毒丸-同仁堂,感觉3种药药效雷同,服药后瘙痒症状缓解。
2021年2月,内服中药组方Ⅰ、中药组方Ⅱ颗粒剂。
患者自述中药组方Ⅰ及中药组方Ⅱ药效比组方3、组方4、皮肤病血毒丸疗效好,止痒效果更好,但不及依巴斯汀对瘙痒的控制好。内服依巴斯汀后,过敏症状即刻得到控制,瘙痒也完全消失,但不久后荨麻疹会再自行复发,症状同前,不会有丝毫减轻。患者坚持依巴斯汀内服治疗6个多月,治疗期间,过敏、瘙痒症状出现即服用依巴斯汀,症状消失则停止服药。6个多月疗程后,慢性自发性荨麻疹发作频次并未降低,风团皮疹、瘙痒未见减轻。
患者8:慢性自发性荨麻疹并发消化系统疾病,男,31岁。
2021年1月14日,患者为急诊科医生,自述荨麻疹患病多年,无明显诱因自行发作,荨麻疹复发时,胳膊、两肩部出现风团疙瘩,后背、大腿内侧出现鲜红色风团皮疹,身体其他部位过敏性风团疙瘩和皮疹泛发且发无定处,瘙痒难耐,常年反复发作。常年有腹泻症状,并伴有胃肠道隐隐作痛,特别是每天凌晨不适感十分突出,特别难受(这也是慢性荨麻疹患者常见的并发消化道疾病)。在用中药组方治疗该病前,用过多种外涂药膏,均无法止痒。推荐患者尝试三种中药组方来控制慢性荨麻疹症状。
中成药荨麻疹丸,1次1袋,早晚各内服1次。患者服药后胃部反酸、腹痛,并产生腹泻,无法控制夜间皮肤剧烈瘙痒,服药2天后停药。
中药组方Ⅰ(成分调整颗粒剂):去炒白术、绵马贯众、黄芩、连翘,加金银花,共5付,每天1付,300ml左右温开水充分溶解,早、晚各半付。此方内服半付后,同时外涂皮肤瘙痒严重的地方,很快全身神经系统放松,感觉皮肤舒适、放松,皮肤神经末梢轻松、感觉灵敏,全身瘙痒得到完全控制,晚上睡觉时瘙痒严重的部位不再痒,感觉轻松,睡眠质量也大大提高。进一步内服该组方,腹泻缓解,凌晨时分胃肠道的不适感消失。
中药组方Ⅱ(与组方Ⅰ成分交叉调整方颗粒剂):去丁香、山茱萸、金银花、生姜、大黄、千里光,加黄芩、连翘、炒白术,共5付,每天1付,300ml左右温开水充分溶解,早、晚各半付。该组方不能完全止痒,而是将体内感染源驱向皮肤,在服用前3付时,胳膊、肩膀、大腿内侧皮肤瘙痒加剧,同时出现较严重的血管性水肿,胳膊、肩膀几处地方出现连接在一起的大包,同时外涂中药组方Ⅱ药液,瘙痒减轻。尽管服药后皮肤过敏症状加剧,但患者自觉起到了积极治疗作用,全身神经系统变得轻松,不再紧张性亢奋。
患者9:慢性自发性荨麻疹,女,60岁。
患者慢性自发性荨麻疹多年,全身皮肤泛发红斑、红疹,面积大小不一,剧烈瘙痒,夜间尤其严重,睡眠质量特别差。治疗2年多,用过多种抗组胺药:马来酸氯苯那敏片、盐酸左西替利嗪片、地氯雷他定片等,疗效甚微。期间也曾多次内服中草药组方汤剂治疗,但控制症状的效果都不好。
2022年3月,经朋友推荐问诊患者1。因该患者为聋哑人,其朋友转述患者瘙痒症状不是很严重,且患者当时皮疹症状也不严重,于是推荐中药组方(中药颗粒剂):甘草9g、薄荷12g、麸炒白术10g、香薷10g、蒲公英10g、射干 10g、金银花10g、忍冬藤15g、桂枝12g、炒牛蒡子10g、牡丹皮10g、白鲜皮 10g、桑叶10g、菊花10g、辛夷10g、黄芪10g、蜜麻黄6g、荆芥10g、苦参6g,共5付19味药,每天1付,300ml温开水内服+外涂皮肤瘙痒剧烈处,早晚各半付或者早、中、晚三次1付。患者内服该组方后,皮肤皮疹突然加重,红斑、红疹伴发血管性水肿,瘙痒加剧,全身泛发,虽外涂组方中药液可以稍微缓解皮肤瘙痒,但皮肤瘙痒仍然严重,且第4、第5付内服后感觉发冷。(分析:患者慢性荨麻疹多年,病情其实很重,该组方不能完全控制住患者症状,但有一定的治疗作用,反而将患者体内的病原体驱至体表皮肤,造成皮疹症状加剧、瘙痒加剧的表现,皮疹伴发皮肤血管性水肿,使患者表现出畏寒的症状。)用完该组方后停止该方。
而后给患者使用中药组方Ⅰ颗粒剂,内服并外涂皮肤瘙痒剧烈处,全身瘙痒发作时联合内服抗组胺药。内服中药组方Ⅰ后,虽皮疹症状仍然严重,但剧烈瘙痒得以缓解,晚上睡眠有改善,服药后体内有温热感散发。用药该组方7 付后,全身红斑、红疹及伴发的皮肤血管性水肿全部消退,浑身瘙痒不明显,夜间睡眠质量大为改善。叮嘱患者继续内服中药组方Ⅰ,控制皮肤症状的同时祛除引发过敏的病原体。
Claims (4)
1.中药组方Ⅰ成分:黄芩、黄连、连翘、紫苏叶、厚朴、白术、白芷、白芍、决明子、黄柏、百部、青蒿、知母、天花粉、甘草、薄荷、绵马贯众、丹参、紫花地丁、大青叶20种中草药的科学提取物。以上20种中草药国家中医药管理局《中华本草》(上海科学技术出版社,1999.9)的推荐剂量是:黄芩3-9g、黄连1.5-8g、连翘6-15g、紫苏叶5-10g、厚朴3-10g、白术3-15g、白芷3-10g、白芍5-12g(15-30g)、决明子6-30g、黄柏3-9g、百部3-10g、青蒿6-15g(20-40g)、知母6-12g、天花粉9-15g、甘草10g、薄荷3-6g、绵马贯众5-15g、丹参5-15g、紫花地丁10-30g、大青叶10-15g。
参照国家中医药管理局《中华本草》(上海科学技术出版社,1999.9)对上述20种成分的推荐剂量和炮制方法,进一步确定各成分及其含量为:黄芩9g-10g、黄连6-8g、连翘10-12g、紫苏叶10g、姜厚朴10-12g、炒白术10g、白芷10-12g、白芍10-12g、炒决明子10-15g、黄柏9-12g、百部10g、青蒿10-12g、盐知母10-12g、天花粉10-12g、甘草9-10g、薄荷6-12g、绵马贯众10-12g、丹参8-10g、紫花地丁10-15g、大青叶10-15g。用该20种成分的科学提取物组成中药组方Ⅰ,制成内服丸剂、散剂或胶囊等内服药;同时用该20种成分的提取物制成外涂药液、药膏或药贴等外涂、外敷用药,配合内服药在皮肤瘙痒剧烈的地方用以外涂、外敷等。
2.中药组方Ⅱ成分:甘草、薄荷、川芎、龙胆草、香薷、蒲公英、大黄、千里光、生姜、金银花、诃子、射干、白头翁、牡丹皮、辛夷、山茱萸、藿香、胡黄连、白鲜皮、荆芥、菊花21种中草药的科学提取物。以上21种中草药国家中医药管理局《中华本草》(上海科学技术出版社,1999.9)的推荐剂量是:甘草10g、薄荷3-6g、川芎3-10g、龙胆3-6g、香薷3-9g、蒲公英10-30g(60g)、大黄3-12g、千里光15-30g、生姜3-10g、金银花10-20g、诃子3-6g、射干5-10g、白头翁15-30g、牡丹皮6-9g、辛夷3-10g、山茱萸5-10g、藿香6-10g、胡黄连6-12g、白鲜皮6-15g、荆芥3-10g、菊花10-15g。
参照国家中医药管理局《中华本草》(上海科学技术出版社,1999.9)对上述21种成分的推荐剂量和炮制方法,进一步确定各成分及其含量为:甘草9-10g、薄荷6-12g、川芎6-10g、龙胆草5-6g、千里光15-20g、白头翁15-20g、香薷9-10g、蒲公英10-15g、金银花10-15g、射干9-10g、牡丹皮9-10g、辛夷9-10g、熟大黄5-6g、生姜9-10g、诃子6-10g、白鲜皮10-12g、山茱萸9-10g、菊花10-12g、荆芥9-10g、胡黄连3g、藿香9-10g。用该21种成分的科学提取物组成中药组方Ⅱ,制成内服丸剂、散剂或胶囊等内服药;同时用该21种成分的提取物制成外涂药液、药膏或药贴等外涂、外敷药,配合内服药在皮肤瘙痒剧烈的地方用以外涂、外敷等。
3.随机选取中药组方Ⅰ、中药组方Ⅱ共39种成分部分成分,组成16至21种中药组方,各成分含量及炮制方法参照国家中医药管理局《中华本草》(上海科学技术出版社,1999.9),科学提取各成分的有效成分,并将有效成分组成中药组方进一步制成内服药或外用药。
4.根据以上权利要求1、2、3项所述,提取以上中草药配方或其中部分成分的有效成分,制成内服型丸剂、散剂、颗粒剂、片剂、胶囊等;或提取配方有效成分制成注射液;提取以上中草药配方或其中部分成分的有效成分,制成外涂药膏、药液、药贴等外用药,或药浴用产品,均在该专利保护范围。该发明治疗各型急慢性荨麻疹、急慢性湿疹、过敏性体质/变态反应体质,兼治过敏性结膜炎、慢性(溃疡性)肠胃炎、慢性过敏性咽炎、类痔疮性肛门瘙痒、过敏性鼻炎、过敏性支气管炎、病毒性流感、口腔疔疮肿毒、过敏体质伴发的关节酸痛及肌肉疼痛,荨麻疹引起的耳道瘙痒、阴部(剧烈)瘙痒、目赤目痒等。
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210353546.XA CN114699493A (zh) | 2022-04-06 | 2022-04-06 | 治疗荨麻疹、湿疹、过敏/变态反应体质的中药组方 |
PCT/CN2022/127828 WO2023193423A1 (zh) | 2022-04-06 | 2022-10-27 | 治疗荨麻疹、湿疹、过敏/变态反应体质的中药组方 |
KR1020247016946A KR20240102982A (ko) | 2022-04-06 | 2022-10-27 | 두드러기, 습진, 알레르기/변태반응체질 치료를 위한 중약제제 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210353546.XA CN114699493A (zh) | 2022-04-06 | 2022-04-06 | 治疗荨麻疹、湿疹、过敏/变态反应体质的中药组方 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114699493A true CN114699493A (zh) | 2022-07-05 |
Family
ID=82173492
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210353546.XA Pending CN114699493A (zh) | 2022-04-06 | 2022-04-06 | 治疗荨麻疹、湿疹、过敏/变态反应体质的中药组方 |
Country Status (3)
Country | Link |
---|---|
KR (1) | KR20240102982A (zh) |
CN (1) | CN114699493A (zh) |
WO (1) | WO2023193423A1 (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115804825A (zh) * | 2022-12-30 | 2023-03-17 | 吴亚坤 | 治疗新冠肺炎、流感病毒的抗微生物中药组方 |
WO2023193423A1 (zh) * | 2022-04-06 | 2023-10-12 | 吴亚坤 | 治疗荨麻疹、湿疹、过敏/变态反应体质的中药组方 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118078763B (zh) * | 2024-04-24 | 2024-08-13 | 江西中医药大学附属医院 | 一种扶正祛湿抗毒颗粒剂及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113769047A (zh) * | 2021-09-14 | 2021-12-10 | 吴亚坤 | 湿疹、过敏/变态反应综合抗微生物疗法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112870320A (zh) * | 2021-01-23 | 2021-06-01 | 吴亚坤 | 荨麻疹、过敏体质、不明原因剧烈瘙痒抗微生物疗法 |
CN114699493A (zh) * | 2022-04-06 | 2022-07-05 | 吴亚坤 | 治疗荨麻疹、湿疹、过敏/变态反应体质的中药组方 |
-
2022
- 2022-04-06 CN CN202210353546.XA patent/CN114699493A/zh active Pending
- 2022-10-27 WO PCT/CN2022/127828 patent/WO2023193423A1/zh active Application Filing
- 2022-10-27 KR KR1020247016946A patent/KR20240102982A/ko unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113769047A (zh) * | 2021-09-14 | 2021-12-10 | 吴亚坤 | 湿疹、过敏/变态反应综合抗微生物疗法 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023193423A1 (zh) * | 2022-04-06 | 2023-10-12 | 吴亚坤 | 治疗荨麻疹、湿疹、过敏/变态反应体质的中药组方 |
CN115804825A (zh) * | 2022-12-30 | 2023-03-17 | 吴亚坤 | 治疗新冠肺炎、流感病毒的抗微生物中药组方 |
Also Published As
Publication number | Publication date |
---|---|
WO2023193423A1 (zh) | 2023-10-12 |
KR20240102982A (ko) | 2024-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN114699493A (zh) | 治疗荨麻疹、湿疹、过敏/变态反应体质的中药组方 | |
CN102670961B (zh) | 一种治疗中老年习惯性便秘的中药 | |
CN115770279B (zh) | 用于治疗慢性下肢静脉疾病的中药组合物及其汤剂和制剂 | |
WO2022156193A1 (zh) | 荨麻疹、过敏/变态反应体质综合抗微生物疗法 | |
CN113769047A (zh) | 湿疹、过敏/变态反应综合抗微生物疗法 | |
CN104740583A (zh) | 一种用于缓解克罗恩病的中药制剂及其制备方法 | |
CN101002848B (zh) | 治疗复发性痛风的药物及其制备方法 | |
CN105412899A (zh) | 一种用于缓解红斑性肢痛病的中药制剂及其制备方法 | |
CN108310070A (zh) | 一种治疗疼痛的中药组合物及其制备方法 | |
CN103301353A (zh) | 一种治疗萎缩性阴道炎的药物组合物 | |
CN112870286A (zh) | 治疗特应性皮炎的中药组合物、制备方法及其应用 | |
CN105561272A (zh) | 一种用于缓解雷诺病的中药制剂及其制备方法 | |
CN104840865A (zh) | 一种治疗痛风性关节炎的中药制剂 | |
CN105616662A (zh) | 一种治疗日光性皮炎的中药组合物 | |
CN104771516A (zh) | 一种治疗过敏性皮炎的中药组合物 | |
CN104873659A (zh) | 治疗湿疹的中药剂及制法 | |
CN111658748A (zh) | 用于治疗痛经的组合物、口服制剂及应用 | |
CN103520475B (zh) | 一种用于治疗皮肤瘙痒的药物组合物 | |
CN113230365B (zh) | 一种治疗关节骨病的中药组合物、制剂及其制备方法和应用 | |
CN104940561A (zh) | 一种治疗眼疾的中药制剂及其制备方法 | |
CN105412392A (zh) | 一种治疗痔疮的中药组合物及其制备方法 | |
CN111228360A (zh) | 一种治疗血热风噪型皮肤病的内服药物及其制备方法 | |
CN104922595A (zh) | 一种用于带状疱疹的中药制剂及其制备方法 | |
CN111388578A (zh) | 一种治疗面瘫的中药组合物及其制备与应用 | |
CN105412599A (zh) | 抗化疗副反应的健脾和胃制剂片剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |